HBV相关慢加急性肝衰竭患者预后危险因素分析

李蓥; 詹婧; 王中峰

doi:10.3969/j.issn.1001-5256.2017.03.020

HBV相关慢加急性肝衰竭患者预后危险因素分析

DOI: 10.3969/j.issn.1001-5256.2017.03.020

1. 吉林大学第一医院胃肠内科内镜中心
2. 吉林大学第一医院肝胆胰内科

详细信息

中图分类号: R512.62;R575.3
计量
- 文章访问数: 2133
- HTML全文浏览量: 18
- PDF下载量: 456
- 被引次数: 0
出版历程
- 出版日期: 2017-03-20

Prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure

Gastrointestinal Endoscopy Center, The First Hospital of Jilin University

摘要

摘要:
目的探讨影响HBV相关慢加急性肝衰竭患者预后的因素,为临床诊治提供依据。方法收集2006年1月1日-2016年1月1日吉林大学第一医院收治的病历资料和随访结果完整的172例HBV相关慢加急性肝衰竭患者,回顾性分析其临床资料及各项实验室指标,找出影响预后的因素。计量资料2组间比较采用成组t检验,计数资料组间比较采用χ2检验,将单因素分析有意义的指标引入logistic多因素回归分析,筛选出影响HBV相关慢加急性肝衰竭患者预后的独立危险因素。结果将单因素分析发现能影响预后的危险因素纳入logistic多因素回归分析,结果显示差异有统计学意义的变量为TBil、PTA、Na+、TC、Child-TurcottePugh评分（CTP评分）、年龄≥50岁、有肝硬化基础、存在胆酶分离、出现并发症（P值分别为0.008、0.002、0.023、0.034、0.001、0.003、0.001、0.004、0.037）。将单因素分析发现能影响预后的并发症进行多因素回归分析,发现差异有统计学意义的变量为肝性脑病、肝肾综合征和感染（P值分别为<0.001、0....
- 肝炎病毒,乙型 /
- 肝功能衰竭 /
- 预后 /
- 危险因素
Abstract:
Objective To investigate the prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure, and to provide a basis for clinical diagnosis and treatment.Methods A total of 172 patients with hepatitis B virus (HBV) -related acute-on-chronic liver failure who were admitted to The First Hospital of Jilin University from January 1, 2006 to January 1, 2016 and had complete medical records and follow-up data were enrolled, and a retrospective analysis was performed for their clinical data and laboratory markers to determine prognostic factors.The independent-samples t test was used for comparison of continuous data between groups, the chi-square test was used for comparison of categorical data between groups, and a multivariate logistic regression analysis was performed for the indices determined to be statistically significant by the univariate analysis to screen out independent risk factors for the prognosis of patients with HBV-related acute-on-chronic liver failure.Results The multivariate logistic regression analysis was performed for the indices determined to be statistically significant by the univariate analysis, and the results showed that the prognostic factors were total bilirubin (TBil) , prothrombin time activity (PTA) , Na+, total cholesterol (TC) , Child-Turcotte-Pugh (CTP) score, age ≥50 years, the presence of liver cirrhosis, bilirubin-enzyme separation, and complications.The multivariate regression analysis was performed for the complications determined to affect prognosis by the univariate analysis, and the results showed that the complications as risk factors were hepatic encephalopathy, hepatorenal syndrome, and infection.Conclusion TBil, PTA, Na+, TC, CTP score, age ≥50 years, the presence of liver cirrhosis, bilirubin-enzyme separation, and complications are independent risk factors for the prognosis of patients with HBV-related acute-on-chronic liver failure.Liver failure patients with hepatic encephalopathy, hepatorenal syndrome, and infection tend to have poorer prognosis.Therefore, early judgment of the prognosis of patients with liver failure is of great importance in the prevention and treatment of related complications.
- hepatitis B virus /
- liver failure /
- prognosis /
- risk factors

HTML全文

参考文献(19)

[1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA;Sever Liver Disease and Artificial Group, Chinese Society of Hepatology, CMA.Guideline for diagnosis and treatment of liver failure[J].Chin J Hepatol, 2013, 21 (3) :177-183. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华肝脏病杂志, 2013, 21 (3) :177-183.

[2]SARIN SK, KEDARISETTY CK, ABBAS Z, et al.Acute-onchronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J].Hepatol Int, 2014, 8 (4) :453-471.

[3]LEI Q, MENG ZJ.Search progress of acute-on-chronic liver failure[J].China Med Herald, 2016, 13 (14) :45-48. (in Chinese) 雷青, 孟忠吉.慢加急性肝衰竭的研究进展[J].中国医药导报, 2016, 13 (14) :45-48.

[4]FU SJ, GAO GS, HU AR, et al.Short-term prognostic value of serum procalcitonin and common inflammation markers combined with CTP score in patients with acute-on-chronic liver failure[J].Chin J Pract Intern Med, 2015, 35 (6) :519-521. (in Chinese) 傅叁君, 高国生, 胡爱荣, 等.血清降钙素原和常用炎症指标联合CTP评分对慢加急性肝衰竭短期预后的预测价值[J].中国实用内科杂志, 2015, 35 (6) :519-521.

[5]JIANG XC.Clinical application of critical disease severity score and its significance[J].Chin Critical Care Med, 2000, 12 (4) :195-197. (in Chinese) 江学成.危重疾病严重程度评分临床应用和意义[J].中国危重病急救医学, 2000, 12 (4) :195-197.

[6]HUANG K, HU JH, WANG HF, et al.Survival and prognostic factors in hepatitis virus-related acute-on-chronic liver failure[J].World J Gastroenterol, 2011, 17 (29) :3448-3452.

[7]LIU C, WANG YM, FAN K.Epidemiological and clinical features of hepatitis B virus related liver failure in China[J].World J Gastroenterol, 2011, 17 (25) :3054-3059.

[8]JALAN R, STADLBAUER V, SEN S, et al.Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on chronic liver failure:a prospective cohort study[J].Crit Care, 2012, 16 (6) :r227.

[9] XIE GJ, ZHANG HY, CHEN Q, et al.Changing etiologies and outcome of liver failure in Southwest China[J].Virol J, 2016, 13:89.

[10]European Association for the Study of the Liver.EASL clinical practice guidelines:management of chronic hepatitis B[J].J Hepatol, 2009, 50 (2) :227-242.

[11]LIU WZ, FENG JH, JIN P, et al.Association between laboratory test results and prognosis in patients with severe hepatitis[J].Chin J Lab Diag, 2010, 14 (5) :752-753. (in Chinese) 刘文芝, 冯继红, 金萍, 等.重型肝炎患者的实验室检测与预后的关系[J].中国实验诊断学, 2010, 14 (5) :752-753.

[12]LIU HX, ZHU YK, MENG QH.Definition, pathophysiology, and clinical management of acute-on-chronic liver failure[J].J Clin Hepatol, 2016, 32 (9) :1684-1687. (in Chinese) 刘海霞, 朱跃科, 孟庆华.慢加急性肝衰竭的定义、病理生理学基础和临床管理[J].临床肝胆病杂志, 2016, 32 (9) :1684-1687.

[13]SHI Y, ZHENG MH, YANG Y, et al.Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation[J].J Gastroenterol Hepatol, 2015, 30 (4) :712-718.

[14]REDDY SS, CIVAN JM.From child-pugh to model for endstage liver disease:deciding who needs a liver transplant[J].Med Clin North Am, 2016, 100 (3) :449-464.

[15]HAN T, ZHANG YL.Predictive and prognostic evaluation of hepatitis B virus-induced liver failure[J].J Clin Hepatol, 2015, 31 (4) :505-509. (in Chinese) 韩涛, 张玉玲.乙型肝炎肝衰竭的早期预警及预后评价[J].临床肝胆病杂志, 2015, 31 (4) :505-509.

[16]JOSHID, O'GRADYJ, PATEL A, et al.Cerebral edema is rare in acute-on-chronic liver failure patients presenting with highgrade hepatic encephalopathy[J].Liver Int, 2014, 34 (3) :362-366.

[17]JALAN R, FERNANDEZ J, WIEST R, et al.Bacterial infections in cirrhosis:a position statement based on the EASL Special Conference 2013[J].J Hepatol, 2014, 60 (6) :1310-1324.

[18]PHILIPS CA, SARIN SK.Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation[J].World J Gastroenterol, 2014, 20 (43) :16037-16052.

[19]CHEN JF, WANG KW, ZHANG SQ, et al.Dexamethasone in outcome of patients with hepatitis B virus-related acute-onchronic liver failure[J].J Gastroenterol Hepatol, 2014, 29 (4) :800-806.

施引文献

资源附件(0)

访问统计